Almost 60% of the minority shareholders in Mediclinic, SA’s biggest private hospital group, have voted against its latest executive pay report, signalling mounting unhappiness among institutional investors about its remuneration policy.

Mediclinic has shed more than 70% of its value in the past three years, thanks to a series of disappointing offshore ventures that saw it write down the value of its investments in the UK-based Spire Healthcare Group and Switzerland’s Hirslanden by a combined £405m in the year to March 31.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.